674 related articles for article (PubMed ID: 8355860)
1. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
[TBL] [Abstract][Full Text] [Related]
2. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
Sabatini D; Fazio S; Cittadini A; Biondi B; Lucariello A; Picano T; Saccà L
Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747
[TBL] [Abstract][Full Text] [Related]
3. Improvement of diastolic function after regression of left ventricular hypertrophy.
Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
[TBL] [Abstract][Full Text] [Related]
4. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of regression of left ventricular hypertrophy after antihypertensive therapy. Comparative echo-Doppler study of ace inhibitors and calcium antagonists].
Totteri A; Scopelliti G; Campanella G; Bertini M; Castro R; Pintus G; Jommi E
Minerva Cardioangiol; 1993 Jun; 41(6):231-7. PubMed ID: 8361609
[TBL] [Abstract][Full Text] [Related]
8. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
10. [Reparative effects of ACE inhibitors on the heart].
Dietz R; Haberbosch W; Osterziel KJ; Förderer T; Busch C
Klin Wochenschr; 1992; 69 Suppl 29():16-24. PubMed ID: 1535402
[TBL] [Abstract][Full Text] [Related]
11. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
Wachtell K; Palmieri V; Gerdts E; Bella JN; Aurigemma GP; Papademetriou V; Dahlöf B; Aalto T; Ibsen H; Rokkedal JE; Devereux RB
Am J Cardiol; 2010 Oct; 106(7):999-1005. PubMed ID: 20854964
[TBL] [Abstract][Full Text] [Related]
13. [Improvement in diastolic function in hypertensive patients with left ventricular hypertrophy with inhibitors of the angiotensin converting enzyme].
Sagastagoitia JD; Morillas M; Martínez A; Lage E; Pallarés C; Ugartemendía C; Asín E; Barrios V; Julia J; Sánchez P; Calvo C; González J; Piña C; García-Barbal J; Arnau C
Rev Clin Esp; 1998 Jan; 198(1):15-22. PubMed ID: 9580230
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
16. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
17. Improvement of diastolic filling in hypertensive patients treated with cilazapril.
Haberbosch W; De Simone R; Dietz R; Waas W; Tillmanns H; Kübler W
J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S159-62. PubMed ID: 1715471
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
[TBL] [Abstract][Full Text] [Related]
19. [Course of the left ventricular mass in a population of 893 hypertensive patients. Effects of treatment with perindopril].
Revel F; Gallois H; Le Coz Y; Richard R; Ollivier JP
Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):594-9. PubMed ID: 7864552
[TBL] [Abstract][Full Text] [Related]
20. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
